Professor
University of Pittsburgh Dept. Pharmaceutical Sci., Pennsylvania, United States
Dr Johnston has 30 years of drug discovery experience in the Pharmaceutical, Biotechnology and Academic sectors. An innovator of cell-based lead generation and optimization, he pioneered the use of high content imaging technology for drug discovery. In 2005, he helped create the University of Pittsburgh Molecular Library Screening Center where he led 21 HTS campaigns and reconfigured the NCI 60 panel for drug combination screening. In 2011, Dr. Johnston established an independent chemical biology research program in the Department of Pharmaceutical Sciences in the School of Pharmacy to implement novel drug discovery strategies to identify new and effective drugs or drug combinations for prostate cancer, melanoma, head and neck cancer, and hepatocellular carcinoma. He provides expertise in HTS/HCS assay development and implementation for collaborations in other therapeutic areas. A founding member of the Society for Biomolecular Imaging and Informatics, he has been a member of SBS and SLAS since 1998.
Disclosure information not submitted.
Sunday, February 6, 2022
8:30 AM – 4:30 PM